<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chan PY</submitter><funding>RCUK | Biotechnology and Biological Sciences Research Council</funding><funding>Wellcome Trust</funding><funding>Center for Strategic Scientific Initiatives, National Cancer Institute</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>CSRD VA</funding><pagination>1672-1683</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12283370</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>57(7)</volume><pubmed_abstract>Metastatic uveal melanoma is an aggressive disease with limited effective therapeutic options. To comprehensively map monogenic and digenic dependencies, we performed CRISPR-Cas9 screening in ten extensively profiled human uveal melanoma cell line models. Analysis involved genome-wide single-gene and combinatorial paired-gene CRISPR libraries. Among our 76 uveal melanoma-specific essential genes and 105 synthetic lethal gene pairs, we identified and validated the CDP-diacylglycerol synthase 2 gene (CDS2) as a genetic dependency in the context of low CDP-diacylglycerol synthase 1 gene (CDS1) expression. We further demonstrate that CDS1/CDS2 forms a synthetic lethal interaction in vivo and reveal that CDS2 knockout results in the disruption of phosphoinositide synthesis and increased cellula</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types.</pubmed_title><pmcid>PMC12283370</pmcid><funding_grant_id>1</funding_grant_id><funding_grant_id>220540/Z/20/A</funding_grant_id><funding_grant_id>BB/T002530/1</funding_grant_id><funding_grant_id>BB/Y006925/1</funding_grant_id><pubmed_authors>Woods M</pubmed_authors><pubmed_authors>Raimondi F</pubmed_authors><pubmed_authors>Stephens L</pubmed_authors><pubmed_authors>Vinceti A</pubmed_authors><pubmed_authors>Thompson NA</pubmed_authors><pubmed_authors>Wessels L</pubmed_authors><pubmed_authors>Mehta I</pubmed_authors><pubmed_authors>Hawkins PT</pubmed_authors><pubmed_authors>van de Haar J</pubmed_authors><pubmed_authors>Bisceglia L</pubmed_authors><pubmed_authors>Adams DJ</pubmed_authors><pubmed_authors>Alexander D</pubmed_authors><pubmed_authors>Goncalves E</pubmed_authors><pubmed_authors>Harle V</pubmed_authors><pubmed_authors>Kozik Z</pubmed_authors><pubmed_authors>Del Castillo Velasco-Herrera M</pubmed_authors><pubmed_authors>Iyer V</pubmed_authors><pubmed_authors>Wong K</pubmed_authors><pubmed_authors>Patiyal S</pubmed_authors><pubmed_authors>Matsuyama LSAS</pubmed_authors><pubmed_authors>Olvera-Leon R</pubmed_authors><pubmed_authors>Vazquez-Cruz ME</pubmed_authors><pubmed_authors>Balmus G</pubmed_authors><pubmed_authors>Arriaga-Gonzalez FG</pubmed_authors><pubmed_authors>Park JS</pubmed_authors><pubmed_authors>van der Weyden L</pubmed_authors><pubmed_authors>Offord V</pubmed_authors><pubmed_authors>Iorio F</pubmed_authors><pubmed_authors>Ryan CJ</pubmed_authors><pubmed_authors>Sinha S</pubmed_authors><pubmed_authors>Chan PY</pubmed_authors><pubmed_authors>Choudhary J</pubmed_authors><pubmed_authors>Venkatesh A</pubmed_authors><pubmed_authors>Barneda D</pubmed_authors><pubmed_authors>Cheema S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types.</name><description>Metastatic uveal melanoma is an aggressive disease with limited effective therapeutic options. To comprehensively map monogenic and digenic dependencies, we performed CRISPR-Cas9 screening in ten extensively profiled human uveal melanoma cell line models. Analysis involved genome-wide single-gene and combinatorial paired-gene CRISPR libraries. Among our 76 uveal melanoma-specific essential genes and 105 synthetic lethal gene pairs, we identified and validated the CDP-diacylglycerol synthase 2 gene (CDS2) as a genetic dependency in the context of low CDP-diacylglycerol synthase 1 gene (CDS1) expression. We further demonstrate that CDS1/CDS2 forms a synthetic lethal interaction in vivo and reveal that CDS2 knockout results in the disruption of phosphoinositide synthesis and increased cellula</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-07-15T06:53:21.162Z</modification><creation>2025-08-16T03:06:08.835Z</creation></dates><accession>S-EPMC12283370</accession><cross_references><pubmed>40615675</pubmed><doi>10.1038/s41588-025-02222-1</doi></cross_references></HashMap>